|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dorfman HA and Czerniak B: Bone cancers.
Cancer. 75(Suppl 1): S203–S210. 1995. View Article : Google Scholar
|
|
3
|
Hayden JB and Hoang BH: Osteosarcoma:
basic science and clinical implications. Orthop Clin North Am.
37:1–7. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wachtel M and Schäfer BW: Targets for
cancer therapy in childhood sarcomas. Cancer Treat Rev. 36:318–327.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kubo T, Piperdi S, Rosenblum J, Antonescu
CR, Chen W, Kim HS, Huvos AG, Sowers R, Meyers PA, Healey JH and
Gorlick R: Platelet-derived growth factor receptor as a prognostic
marker and a therapeutic target for imatinib mesylate therapy in
osteosarcoma. Cancer. 112:2119–2129. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferrari S and Palmerini E: Adjuvant and
neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr
Opin Oncol. 19:341–346. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang WG, Ye L, Ji K, Frewer N, Ji J and
Mason MD: Inhibitory effects of Yangzheng Xiaoji on
angiogenesis and the role of the focal adhesion kinase pathway. Int
J Oncol. 41:1635–1642. 2012.
|
|
8
|
Ye L, Ji K, Frewer N, Ji J and Jiang WG:
Impact of Yangzheng Xiaoji on the adhesion and migration of
human cancer cells: the role of the AKT signalling pathway.
Anticancer Res. 32:2537–2543. 2012.
|
|
9
|
Zhang SY, Gu CH, Gao XD and Wu YL: A
random, double-blinded and multicentre study of chemotherapy
assisted Yangzheng Xiaoji capsule on treating primary hepatic
carcinoma. Chin J Diffic Compl Case. 8:461–464. 2009.
|
|
10
|
Wang QL, Xuo CM, Wu XP, Li YX and Bi XJ:
Treatment of atypical gastric dysplasia using Yangzheng Xiaoji.
Chin J Diffic Compl Case. 7:38–39. 2009.
|
|
11
|
Ye Li, Ji K, Ji JF, Hargest R and Jiang
WG: Application of electric cell-substrate impedance sensing in
evaluation of traditional medicine on the cellular functions of
gastric and colorectal cancer cells. Cancer Metastasis Biol Treat.
17:195–202. 2012.
|
|
12
|
Jiang WG, Hiscox S, Hallett MB, Scott C,
Horrobin DF and Puntis MC: Inhibition of hepatocyte growth
factor-induced motility and in vitro invasion and motility of human
colon cancer cells by gamma-linolenic acid. Br J Cancer.
71:744–752. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giaever I and Keese CR: Micromotion of
mammalian cells measured electrically. Proc Natl Acad Sci USA.
88:7896–7900. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Keese CR, Wegener J, Walker SR and Giaever
I: Electrical wound-healing assay for cells in vitro. Proc Natl
Acad Sci USA. 101:1554–1559. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang WG, Martin TA, Lewis-Russell JM,
Douglas-Jones A, Ye L and Mansel RE: Eplin-alpha expression in
human breast cancer, the impact on cellular migration and clinical
outcome. Mol Cancer. 7:712008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davies G, Mason MD, Martin TA, Parr C,
Watkins G, Lane J, Matsumoto K, Nakamura T and Jiang WG: The HGF/SF
antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor
growth and angiogenesis in vivo. Int J Cancer. 106:348–354. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye L, Martin TA, Parr C, Harrison GM,
Mansel RE and Jiang WG: Biphasic effects of 17-β-estradiol on
expression of occludin and transendothelial resistance and
paracellular permeability in human vascular endothelial cells. J
Cell Physiol. 196:362–369. 2003.
|
|
18
|
Gilmore AP and Romer LH: Inhibition of
focal adhesion kinase (FAK) signaling in focal adhesions decreases
cell motility and proliferation. Mol Biol Cell. 7:1209–1224. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen JY, Tang YA, Huang SM, Juan HF, Wu
LW, Sun YC, Wang SC, Wu KW, Balraj G, Chang TT, Li WS, Cheng HC and
Wang YC: A novel sialyltransferase inhibitor suppresses
FAK/paxillin signaling and cancer angiogenesis and metastasis
pathways. Cancer Res. 71:473–483. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stokes JB, Adair SJ, Slack-Davis JK,
Walters DM, Tilghman RW, Hershey ED, Lowrey B, Thomas KS, Bouton
AH, Hwang RF, Stelow EB, Parsons JT and Bauer TW: Inhibition of
focal adhesion kinase by PF-562,271 inhibits the growth and
metastasis of pancreatic cancer concomitant with altering the tumor
microenvironment. Mol Cancer Ther. 10:2135–2145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Halder J, Lin YG, Merritt WM, Spannuth WA,
Nick AM, Honda T, Kamat AA, Han LY, Kim TJ, Lu C, Tari AM, Bornmann
W, Fernandez A, Lopez-Berestein G and Sood AK: Therapeutic efficacy
of a novel focal adhesion kinase inhibitor TAE226 in ovarian
carcinoma. Cancer Res. 67:10976–10983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Infante JR, Camidge DR, Mileshkin LR, Chen
EX, Hicks RJ, Rischin D, Fingert H, Pierce KJ, Xu H, Roberts WG,
Shreeve SM, Burris HA and Siu LL: Safety, pharmacokinetic, and
pharmacodynamic phase I dose-escalation trial of PF-00562271, an
inhibitor of focal adhesion kinase, in advanced solid tumors. J
Clin Oncol. 30:1527–1533. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Soria JC, Plummer R, Ranson M, Gan H,
Arkenau HT, Zalcman G, Blagden S, Evans TRJ, Peddareddigari V,
Mazumdar J, Murray S, Gidson D, Fleming RA, Auger K and Millward M:
Loss of the tumor suppressor merlin as a potential predictive
biomarker of clinical activity for the oral, focal adhesion kinase
(FAK) inhibitor GSK2256098 in pts with recurrent
mesothelioma. Eur J Cancer. 48(Suppl 6): S1882012. View Article : Google Scholar
|
|
24
|
Ritter J and Bielack SS: Osteosarcoma. Ann
Oncol. 21(Suppl 7): vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Anninga JK, Gelderblom H, Fiocco M, Kroep
JR, Taminiau AH, Hogendoorn PC and Egeler RM: Chemotherapeutic
adjuvant treatment for osteosarcoma: where do we stand? Eur J
Cancer. 47:2431–2445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jaffe N: Osteosarcoma: review of the past,
impact on the future. The American experience. Cancer Treat Res.
152:239–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
